90OThe role of dose-dense (DD) adjuvant chemotherapy (CT) in HER2-positive (HER2+) early breast cancer (BC) patients (pts) before and after the introduction of trastuzumab (T): Exploratory analysis of the GIM2 trial. (13th May 2019) - Lambertini, M; Bruzzone, M; Poggio, F; Conte, B; de Azambuja, E; Bisagni, G; De Laurentiis, M; de Placido, S; Cognetti, F; Del Mastro, L